Serum androgen markers in preeclampsia

Nora R. Miller, David Garry, Hillel W. Cohen, Reinaldo Figueroa

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

OBJECTIVE: To determine whether maternal serum levels of androgens are associated with preeclampsia in primigravid women. STUDY DESIGN: A case-control study of primigravid women with singleton pregnancies. Women diagnosed with preeclampsia (n = 15) were matched with normotensive controls (n = 30) for age and gestational age. Serum testosterone, sex hormone binding globulin, estradiol and dehydroepiandrosterone sulfate were measured before delivery. The study had 80% power to detect a 30% difference in mean testosterone concentration between cases and controls using a two-tailed test and α level of .05. The Student t test, Mann-Whitney U test, Wilcoxon signed ranks test and χ 2 analysis of proportions were used for analysis. RESULTS: Cases and controls did not differ in maternal age, gestational age, body mass index, tobacco use or neonatal sex. As compared with normotensive controls, preeclamptic women exhibited no statistically significant differences in median levels of total testosterone, free androgen index, sex hormone binding globulin, estradiol or dehydroepiandrosterone sulfate. CONCLUSION: Maternal serum levels of androgens do not exhibit an association with preeclampsia in primigravid women.

Original languageEnglish (US)
Pages (from-to)225-229
Number of pages5
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume48
Issue number4
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Pre-Eclampsia
Androgens
Biomarkers
Testosterone
Sex Hormone-Binding Globulin
Dehydroepiandrosterone Sulfate
Nonparametric Statistics
Gestational Age
Serum
Mothers
Maternal Age
Tobacco Use
Case-Control Studies
Body Mass Index
Students
Pregnancy
estradiol sulfate

Keywords

  • Androgens
  • Dehydroepiandrosterone sulfate
  • Pre-eclampsia
  • Sex hormone-binding globulin
  • Testosterone

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Miller, N. R., Garry, D., Cohen, H. W., & Figueroa, R. (2003). Serum androgen markers in preeclampsia. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 48(4), 225-229.

Serum androgen markers in preeclampsia. / Miller, Nora R.; Garry, David; Cohen, Hillel W.; Figueroa, Reinaldo.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 48, No. 4, 01.04.2003, p. 225-229.

Research output: Contribution to journalArticle

Miller, NR, Garry, D, Cohen, HW & Figueroa, R 2003, 'Serum androgen markers in preeclampsia', Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 48, no. 4, pp. 225-229.
Miller, Nora R. ; Garry, David ; Cohen, Hillel W. ; Figueroa, Reinaldo. / Serum androgen markers in preeclampsia. In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 2003 ; Vol. 48, No. 4. pp. 225-229.
@article{17797abcad5c4e328369aab4e19fe82d,
title = "Serum androgen markers in preeclampsia",
abstract = "OBJECTIVE: To determine whether maternal serum levels of androgens are associated with preeclampsia in primigravid women. STUDY DESIGN: A case-control study of primigravid women with singleton pregnancies. Women diagnosed with preeclampsia (n = 15) were matched with normotensive controls (n = 30) for age and gestational age. Serum testosterone, sex hormone binding globulin, estradiol and dehydroepiandrosterone sulfate were measured before delivery. The study had 80{\%} power to detect a 30{\%} difference in mean testosterone concentration between cases and controls using a two-tailed test and α level of .05. The Student t test, Mann-Whitney U test, Wilcoxon signed ranks test and χ 2 analysis of proportions were used for analysis. RESULTS: Cases and controls did not differ in maternal age, gestational age, body mass index, tobacco use or neonatal sex. As compared with normotensive controls, preeclamptic women exhibited no statistically significant differences in median levels of total testosterone, free androgen index, sex hormone binding globulin, estradiol or dehydroepiandrosterone sulfate. CONCLUSION: Maternal serum levels of androgens do not exhibit an association with preeclampsia in primigravid women.",
keywords = "Androgens, Dehydroepiandrosterone sulfate, Pre-eclampsia, Sex hormone-binding globulin, Testosterone",
author = "Miller, {Nora R.} and David Garry and Cohen, {Hillel W.} and Reinaldo Figueroa",
year = "2003",
month = "4",
day = "1",
language = "English (US)",
volume = "48",
pages = "225--229",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "4",

}

TY - JOUR

T1 - Serum androgen markers in preeclampsia

AU - Miller, Nora R.

AU - Garry, David

AU - Cohen, Hillel W.

AU - Figueroa, Reinaldo

PY - 2003/4/1

Y1 - 2003/4/1

N2 - OBJECTIVE: To determine whether maternal serum levels of androgens are associated with preeclampsia in primigravid women. STUDY DESIGN: A case-control study of primigravid women with singleton pregnancies. Women diagnosed with preeclampsia (n = 15) were matched with normotensive controls (n = 30) for age and gestational age. Serum testosterone, sex hormone binding globulin, estradiol and dehydroepiandrosterone sulfate were measured before delivery. The study had 80% power to detect a 30% difference in mean testosterone concentration between cases and controls using a two-tailed test and α level of .05. The Student t test, Mann-Whitney U test, Wilcoxon signed ranks test and χ 2 analysis of proportions were used for analysis. RESULTS: Cases and controls did not differ in maternal age, gestational age, body mass index, tobacco use or neonatal sex. As compared with normotensive controls, preeclamptic women exhibited no statistically significant differences in median levels of total testosterone, free androgen index, sex hormone binding globulin, estradiol or dehydroepiandrosterone sulfate. CONCLUSION: Maternal serum levels of androgens do not exhibit an association with preeclampsia in primigravid women.

AB - OBJECTIVE: To determine whether maternal serum levels of androgens are associated with preeclampsia in primigravid women. STUDY DESIGN: A case-control study of primigravid women with singleton pregnancies. Women diagnosed with preeclampsia (n = 15) were matched with normotensive controls (n = 30) for age and gestational age. Serum testosterone, sex hormone binding globulin, estradiol and dehydroepiandrosterone sulfate were measured before delivery. The study had 80% power to detect a 30% difference in mean testosterone concentration between cases and controls using a two-tailed test and α level of .05. The Student t test, Mann-Whitney U test, Wilcoxon signed ranks test and χ 2 analysis of proportions were used for analysis. RESULTS: Cases and controls did not differ in maternal age, gestational age, body mass index, tobacco use or neonatal sex. As compared with normotensive controls, preeclamptic women exhibited no statistically significant differences in median levels of total testosterone, free androgen index, sex hormone binding globulin, estradiol or dehydroepiandrosterone sulfate. CONCLUSION: Maternal serum levels of androgens do not exhibit an association with preeclampsia in primigravid women.

KW - Androgens

KW - Dehydroepiandrosterone sulfate

KW - Pre-eclampsia

KW - Sex hormone-binding globulin

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=0346783410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346783410&partnerID=8YFLogxK

M3 - Article

C2 - 12746983

AN - SCOPUS:0346783410

VL - 48

SP - 225

EP - 229

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 4

ER -